Announced Sat, 11 Apr · 14:15 IST

Certificate under Reg. 74 (5) of SEBI (DP) Regulation, 2018

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.0%1-day move

₹144.85

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+4.0+6.1+4.7+2.7—-0.4+21.0+28.3+46.2+62.4

Up moveDown movePending

AI summary

Aptus Pharma Ltd has submitted a compliance certificate under SEBI Regulation 74(5) for the half-year ending 31st March 2026. The certificate confirms compliance with dematerialization requirements and was issued by Accurate Securities & Registry Private Limited, the company's Registrar and Share Transfer Agent. This is a standard regulatory filing required to be submitted to BSE within the stipulated timeframe. The filing was signed by Managing Director Tejash Hathi on 11th April 2026.

Likely market impact

This is a routine regulatory compliance filing with no direct impact on stock price or shareholder value. It confirms the company's dematerialization records are in order with its registrar.